Isospec Analytics hat dies direkt geteilt
🇫🇮 Awesome experience presenting Isospec Analytics at Slush, DM me if you want to have a chat about the future of dynamic health monitoring.
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are unlocking the potential of glycomics and metabolomics in disease biomarker discovery and for the development of safer nutritional and pharmaceutical products.
Externer Link zu Isospec Analytics
Lausanne, Vaud 1015, CH
Isospec Analytics hat dies direkt geteilt
🇫🇮 Awesome experience presenting Isospec Analytics at Slush, DM me if you want to have a chat about the future of dynamic health monitoring.
Isospec Analytics hat dies direkt geteilt
We are at Forum EPFL today with Wissem looking out for interns in ML/AI to extend our pipelines! Come check us out! Join Isospec Analytics and help us leverage the full power of glycomics and metabolimics for biomarker discovery 🔬🧑🔬
We’re at Ilmac today and tomorrow, make sure to stop by our stand if you are interested in in learning how we can help you navigate the complexity of you biological samples!
📢 Big day for us at Isospec! 🛩 📦 The first instrument featuring our tech to our customer's site. The Synapt G2S which we've upgraded with our cryogenic ion trap technology in collaboration with MSVision, is on its way to Kevin Pagel's lab in Berlin. 🚀 🚀 It's pretty surreal seeing our tech leave the nest. Can't wait to see what kinds of molecular mysteries it'll help solve out there in the wild! 👉 If you're curious about what Isospec's Cryo IR technology can do for your research, drop us a line. We're always up for a chat about the next big thing in molecular analysis. #MolecularIntelligence #BiotechInnovation #MassSpectrometry #IRspectroscopy
Isospec Analytics hat dies direkt geteilt
Wie das Schweizer Biotech-Unternehmen Isospec Analytics mit Schnelldiagnosen des Blutbilds deutlich mehr Moleküle sichtbar machen kann – und so viel schneller und früher als zuvor Krankheiten von Krebs bis Diabetes auf die Spur kommen will. Jetzt lesen: https://lnkd.in/d4ursZmh #Forbes #ForbesDA #IsospecAnalytics #Biotech
📢 Big news from Isospec!! We are thrilled to announce that we secured a $1.9M pre-seed round to accelerate the growth of our molecular identification services and the development of our biomarker discovery platform! Check out the story on Forbes! https://lnkd.in/eKghEcWT
The first direct online coupling of cryogenic gas-phase IR to liquid chromatography is reported in our latest publication in Analytical Chemistry! Give it a read - it's open access... https://lnkd.in/eN2CBBfg #analyticalchemistry #glycans #nutrition #HMO #lcms
🌟 It is time to expand our team! We have positions available in our: 1) Applications team as a bioanalytical specialist 2) Software team as a data engineer / product architect! If you're someone who thrives in a fast-paced environment, values creativity, and loves tackling challenges head-on, we want to hear from you! Join us in shaping the future of the life science industry. Drop a message or apply using the links below: Bioanalytical specialist: https://lnkd.in/eRx3tvPq Data engineer / product architect: https://lnkd.in/e8--H6y9 Feel free to tag someone who might fit the job descriptions or share with your network!
🔬 Excited to be a speaker at the HS-SEQ Berlin Symposium tomorrow! Join me as I delve into how Isospec Analytics’s groundbreaking technology is revolutionizing glycan structure identification and unlocking the secrets of the glycan code. 🤝 Thanks to our partnership with MSVision, we are writing a new chapter in glycan identification! Our technology is now available as an add-on to Synapt instruments, combining the selectivity and sensitivity of ion mobility and mass spec, with the outstanding structural identification capabilities of cryo IR spectroscopy. Looking forward to connecting with fellow enthusiasts and experts at the conference! Feel free to reach out or catch me after the session for a chat. See you there! 🚀 #Glycomics #Technology #ConferenceSpeaker #Innovation
Letzte Runde
Fremdfinanzierung109.351,00 $
Investor:innen
Foundation for Innovation and Technology (FIT)